Key facts
- It has raised $138.7M; the latest was Later Stage VC ($8.7M) in Oct 2025.
- Notable investors include Gaingels, Calm Ventures, JIC Venture Growth Investments, Alpha Wave Global, Zain S Hasan Charitable Remainder Trust — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Beren Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Beren Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Beren Therapeutics
Operator of a biotechnology company intended to develop innovative and efficacious therapies to make them accessible to every patient. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Thousand Oaks, CA, United States
- Founded
- 2020
- Website
- berentx.com/
- Ownership
- Privately Held (backing)
Beren Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Beren Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Beren Therapeutics in its N-PORT filings yet. We sweep new filings monthly.